Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix Expands DPNCheck Commercialization in Mexico

Business Wire July 13, 2016

NeuroMetrix’ Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting

Business Wire July 12, 2016

NeuroMetrix Announces Launch of Quell Sport Electrode

Business Wire July 7, 2016

NeuroMetrix Reports Peer-Reviewed Publication of Initial Quell Study

Business Wire July 6, 2016

NeuroMetrix Announces Quell Distribution Agreement with WBC Group

Business Wire June 28, 2016

NeuroMetrix to Sponsor Clinical Study at the Scripps Translational Science Institute Assessing the Impact of Quell Technology on Opioid Use and Pain in Cancer Patients

Business Wire June 27, 2016

NeuroMetrix Submits CE Mark Application for Quell Wearable Pain Relief Device

Business Wire June 22, 2016

NeuroMetrix Showcases Quell Technology at the Western Foot & Ankle Conference

Business Wire June 21, 2016

NeuroMetrix Announces Quell Distribution in Canada

Business Wire June 14, 2016

NeuroMetrix Reports Executive Stock Transactions during May 2016

Business Wire June 10, 2016

NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies

Business Wire June 9, 2016

NeuroMetrix Closes $21.3 Million At-The-Market Private Placement of Preferred Stock and Warrants and Redeems $13.8 Million of Outstanding Preferred Stock

Business Wire June 8, 2016

NeuroMetrix Celebrates 20 Year Anniversary

Business Wire June 6, 2016

NeuroMetrix Announces $21.3 Million at the Market Private Placement of Preferred Stock and Warrants

Business Wire June 2, 2016

NeuroMetrix Announces Availability of Quell in Approximately 1,000 Chain Drug Stores

Business Wire June 2, 2016

NeuroMetrix to Present at the LD Micro Invitational Conference on June 7, 2016

Business Wire May 31, 2016

NeuroMetrix Reports the Launch of the Quell® Health Cloud for Android

Business Wire May 26, 2016

NeuroMetrix Announces Frank McGillin, SVP and General Manager, Consumer to participate in a Digital Health Summer Summit Panel at BIO 2016

Business Wire May 18, 2016

NeuroMetrix Announces Availability of Quell at Brookstone.com

Business Wire May 16, 2016

NeuroMetrix Announces Launch of National TV Campaign to Support Quell

Business Wire May 12, 2016